H2 receptor antagonists safer than PPI for stress ulcer prevention

01/17/2014 | Medscape (free registration)

Critically ill patients who received proton pump inhibitors for stress ulcer prophylaxis were significantly more likely to suffer adverse events such as gastrointestinal bleeding and 30-day mortality than those who received histamine 2 receptor antagonists, according to a study presented at the SCCM Critical Care Congress. The PPI group also had a slightly higher risk of nosocomial pneumonia and Clostridium difficile infection than those who took H2 receptor antagonists.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA